57 results on '"Straughn, J.M."'
Search Results
2. Gynecologic oncology patients are ready for telemedicine in routine care: Results from a pre-COVID survey
3. Inpatient chemotherapy for gynecologic cancer: When is it worth it?
4. Improving the surgical experience in gynecologic oncology patients with use of patient engagement technology: A prospective cohort study
5. Patient satisfaction of a restrictive opioid prescribing algorithm in gynecologic oncology patients undergoing surgery
6. Minimally invasive hysterectomy rates and surgical outcomes in uterine cancer: A Society of Gynecologic Oncology clinical outcomes registry analysis
7. Addressing the opioid epidemic in gynecologic oncology patients through a restrictive opioid prescribing practice
8. Risk factors for readmission among gynecologic oncology patients managed with an enhanced recovery after surgery protocol
9. The impact of code status simplification on end-of-life health care choices in gynecologic oncology
10. Enhanced recovery protocols decrease complication rates in all patients with a greater impact on the morbidly obese population
11. Prehabilitation is a cost-saving method with improved outcomes for medically frail patients undergoing surgery for epithelial ovarian cancer: A cost-effectiveness analysis
12. Compliance with a sepsis care pathway and its impact on morbidity and mortality in gynecologic oncology patients
13. Reducing short interval advanced imaging in gynecologic oncology patients presenting to the emergency department
14. A cost analysis of the impact of enhanced recovery after surgery (ERAS) protocol in gynecologic oncology surgery
15. Phase IB dose escalation and expansion trial of the oral hedgehog inhibitor sonidegib (LDE225) and weekly paclitaxel in platinum-resistant ovarian cancer (NCT02195973)
16. Impact of enhanced recovery after surgery (ERAS) protocol on postoperative pain control in chronic narcotic users
17. Evaluation of postoperative mortality in octogenarians with advanced epithelial ovarian cancer
18. Pembrolizumab in advanced recurrent endometrial cancer: A cost-effectiveness analysis
19. Impact of enhanced recovery after surgery (ERAS) protocol on the gastrointestinal tract in gynecologic oncology patients undergoing laparotomy
20. Implementation of a genomic profiling program for gynecologic malignancies: An achievable clinical option
21. Impact of enhanced recovery after surgery (ERAS) protocol on the gastrointestinal tract in gynecologic oncology patients undergoing laparotomy
22. Using gene expression and DNA mutations to predict recurrence in high-intermediate risk endometrial cancer
23. Racial disparities in hereditary gynecologic cancer risk assessment: What and why?
24. Timing of robotic hysterectomy after cervical excisional procedure and associated perioperative complications
25. Timing of robotic hysterectomy after cervical excisional procedure and associated perioperative complications
26. Inhibiting the wnt/β-catenin pathway modulates immune response in ovarian cancer
27. Inhibiting the wnt/β-catenin pathway modulates immune response in ovarian cancer
28. Implementation of a genomic profiling program for gynecologic malignancies: An achievable clinical option
29. Hospital readmissions in gynecologic oncology patients: A target for quality improvement
30. Demographic and geographic factors associated with advanced cervical cancer in a rural state
31. Using value-based tools to determine the value of bevacizumab in cervical and ovarian cancer
32. Evaluation of major postoperative complications in gynecologic oncology patients undergoing bowel surgery: A quality improvement project
33. RNA expression patterns in human ascites-derived ovarian cancer cells allow molecular characterization and identification of potential therapeutic targets
34. Using DrugAbacus to determine the value of PD-1 inhibitors in ovarian cancer: How much should they cost?
35. Correlation between frozen section and final pathology in women with suspected gynecologic malignancies
36. Molecular response to neoadjuvant chemotherapy in high-grade serous ovarian carcinoma
37. Augmenting the MHC II antigen-presentation pathway with epigenetic therapy in epithelial ovarian cancer
38. Quantitative and qualitative evaluation of pediatrician attitudes and barriers to HPV vaccination
39. The impact of physician burnout on clinical and academic productivity of gynecologic oncologists: A decision analysis
40. Predictors of unplanned reoperation for ovarian cancer patients from the National Surgical Quality Improvement Program database
41. Molecular response to neoadjuvant chemotherapy in high-grade serous ovarian carcinoma
42. Improved outcomes following the use of dose-dense paclitaxel-based neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma
43. Optimal according to whom? Interobserver variability in surgical cytoreduction for advanced ovarian carcinoma
44. Sentinel lymph node biopsy for patients with low-risk endometrial adenocarcinoma: A cost-effectiveness analysis
45. Early warning score: An indicator of adverse outcomes in postoperative patients on a gynecologic oncology service
46. Effective outpatient management of carboplatin hypersensitivity reactions in gynecologic oncology patients
47. The Society of Gynecologic Oncology Clinical Outcomes Registry: A single-institution experience
48. Are hospital readmissions an accurate measure of quality cancer care in gynecologic oncology patients?
49. What is the impact of distance from a comprehensive cancer center on survival in patients with cervical cancer?
50. Long-term safety follow-up, dosimetry and immunologic responses in patients enrolled on a phase I trial of intraperitoneal 212Pb labeled trastuzumab
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.